RELESE Trademark

Trademark Overview

On Thursday, July 22, 2021, a trademark application was filed for RELESE with the United States Patent and Trademark Office. The USPTO has given the RELESE trademark a serial number of 90842320. The federal status of this trademark filing is REGISTERED as of Tuesday, June 27, 2023. This trademark is owned by Stimlabs LLC. The RELESE trademark is filed in the Pharmaceutical Products category with the following description:

Human placental membrane allograft tissue for the non-surgical treatment of acute and chronic skin wounds
relese

General Information

Serial Number90842320
Word MarkRELESE
Filing DateThursday, July 22, 2021
Status700 - REGISTERED
Status DateTuesday, June 27, 2023
Registration Number7094420
Registration DateTuesday, June 27, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements

Goods and ServicesHuman placental membrane allograft tissue for the non-surgical treatment of acute and chronic skin wounds
Pseudo MarkRELEASE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 22, 2021
Primary Code005
First Use Anywhere DateMonday, April 24, 2023
First Use In Commerce DateMonday, April 24, 2023

Trademark Owner History

Party NameStimlabs LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressRoswell, GA 30076
Party NameStimlabs LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRoswell, GA 30076
Party NameStimlabs LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRoswell, GA 30076

Trademark Events

Event DateEvent Description
Tuesday, June 27, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 27, 2023REGISTERED-PRINCIPAL REGISTER
Friday, May 26, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, May 25, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 9, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 2, 2023USE AMENDMENT FILED
Tuesday, May 2, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, April 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 17, 2023SOU EXTENSION 1 GRANTED
Thursday, February 23, 2023SOU EXTENSION 1 FILED
Thursday, April 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, February 25, 2023NOTICE OF REVIVAL - E-MAILED
Saturday, February 25, 2023EXTENSION RECEIVED WITH TEAS PETITION
Saturday, February 25, 2023PETITION TO REVIVE-GRANTED
Saturday, February 25, 2023TEAS PETITION TO REVIVE RECEIVED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, May 25, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 25, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, May 25, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 20, 2022NON-FINAL ACTION E-MAILED
Wednesday, April 20, 2022NON-FINAL ACTION WRITTEN
Monday, April 18, 2022ASSIGNED TO EXAMINER
Wednesday, September 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 26, 2021NEW APPLICATION ENTERED

Related Keywords

relese acute chronic skin wounds treatment surgical placental membrane allograft tissue